AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 13.346
NA - Nord America 8.050
EU - Europa 3.556
SA - Sud America 1.057
Continente sconosciuto - Info sul continente non disponibili 419
AF - Africa 121
OC - Oceania 57
Totale 26.606
Nazione #
HK - Hong Kong 9.097
US - Stati Uniti d'America 7.839
SG - Singapore 1.841
IT - Italia 1.358
CN - Cina 854
BR - Brasile 802
VN - Vietnam 669
RU - Federazione Russa 412
UA - Ucraina 355
DE - Germania 331
IE - Irlanda 224
FR - Francia 200
TR - Turchia 199
KR - Corea 162
SE - Svezia 158
GB - Regno Unito 142
BD - Bangladesh 121
EE - Estonia 107
AR - Argentina 100
CA - Canada 100
IN - India 98
FI - Finlandia 75
JP - Giappone 53
MX - Messico 53
EC - Ecuador 43
IQ - Iraq 41
PL - Polonia 36
ID - Indonesia 35
NL - Olanda 33
ZA - Sudafrica 33
PK - Pakistan 32
AU - Australia 31
CO - Colombia 30
VE - Venezuela 27
ES - Italia 24
NZ - Nuova Zelanda 24
UZ - Uzbekistan 21
CZ - Repubblica Ceca 19
CL - Cile 17
PY - Paraguay 17
AT - Austria 16
KE - Kenya 16
MA - Marocco 16
JM - Giamaica 14
MY - Malesia 13
SA - Arabia Saudita 12
TN - Tunisia 11
DZ - Algeria 10
PH - Filippine 10
AZ - Azerbaigian 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
IL - Israele 8
JO - Giordania 8
AL - Albania 7
BA - Bosnia-Erzegovina 7
LB - Libano 7
LT - Lituania 7
OM - Oman 7
CH - Svizzera 6
EG - Egitto 6
KZ - Kazakistan 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
BO - Bolivia 5
EU - Europa 5
HN - Honduras 5
GT - Guatemala 4
HR - Croazia 4
NI - Nicaragua 4
SN - Senegal 4
BH - Bahrain 3
BS - Bahamas 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
LY - Libia 3
MD - Moldavia 3
ME - Montenegro 3
MN - Mongolia 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
BW - Botswana 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
IR - Iran 2
KH - Cambogia 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MM - Myanmar 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
Totale 26.160
Città #
Hong Kong 9.079
Ann Arbor 1.105
Singapore 881
San Jose 869
Milan 578
Princeton 518
Chandler 510
Ashburn 480
Wilmington 472
Dallas 443
Jacksonville 433
Houston 260
Beijing 214
Dublin 210
Woodbridge 201
Council Bluffs 194
Izmir 166
Ho Chi Minh City 165
The Dalles 160
Lauterbourg 155
Rome 152
Dong Ket 136
Hanoi 131
Los Angeles 124
Nanjing 112
Moscow 111
Tallinn 107
Andover 104
Santa Clara 93
New York 89
Boardman 86
Salerno 72
São Paulo 72
Munich 65
Pellezzano 64
Düsseldorf 55
Norwalk 53
Naples 52
Figino 49
Buffalo 45
Dearborn 44
Shenyang 43
Nanchang 39
Tokyo 36
Fairfield 34
Mestre 34
San Francisco 33
Haiphong 31
Frankfurt am Main 29
Hebei 29
Montreal 29
Rio de Janeiro 29
Memphis 27
Warsaw 27
Brooklyn 26
Redwood City 26
Jiaxing 25
Da Nang 24
Atlanta 23
Chicago 23
Nuremberg 23
Turin 23
Chennai 22
Orem 22
Changsha 21
Pune 21
Amsterdam 20
London 20
Mexico City 20
Tashkent 19
Boston 18
San Diego 18
Tianjin 18
Washington 18
Baghdad 17
Phoenix 17
Seattle 17
Bologna 16
Denver 16
Poplar 16
Belo Horizonte 15
Guarulhos 15
Nairobi 15
Stockholm 15
Ankara 14
Brasília 14
Casoria 14
Curitiba 14
Porto Alegre 14
Quito 14
Shanghai 14
Biên Hòa 13
Guangzhou 13
Philadelphia 13
Seoul 13
Turku 13
Caracas 12
Guayaquil 12
Kingston 12
Auckland 11
Totale 20.128
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 1.005
Sex Differences in Parkinson’s Disease: From Bench to Bedside 652
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 621
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 604
Gender differences in microRNA expression in levodopa-naive PD patients 580
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 549
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 533
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 532
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 518
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 440
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 424
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 407
The most effective way to obtain long-term memory is to increase first presentation duration of single words 375
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 333
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 330
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 297
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 291
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 279
Classifying Different Stages of Parkinson’s Disease Through Random Forests 272
Metabolomics in Parkinson's disease 263
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 248
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 248
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 226
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 217
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 214
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 209
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 204
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 200
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 198
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 192
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 186
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 183
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 179
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 178
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 171
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 169
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 166
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 163
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 161
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 159
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 159
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 156
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 155
Quitting smoking: An early non-motor feature of Parkinson's disease? 154
Increased bilirubin levels in de novo Parkinson's disease 152
Abnormal eating behaviors in progressive supranuclear palsy. 150
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 149
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 149
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 148
Machine learning can predict mild cognitive impairment in Parkinson's disease 143
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 143
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 142
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 142
Clinical and neurological abnormalities in adult celiac disease. 139
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 138
Bisphenol A glucuronidation in patients with Parkinson's disease 137
Freezing of gait and executive functions in patients with Parkinson’s disease 137
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 134
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 133
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 131
Gender and non motor fluctuations in Parkinson's disease: A prospective study 128
Cognitive correlates of “pure apathy” in Parkinson's disease 128
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 127
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 124
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 123
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 121
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 121
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 120
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 119
“Response to Apomorphine in early Parkinson’s disease”. 118
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 118
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 117
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 117
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 115
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 115
Uric acid relates to dopamine transporter availability in Parkinson's disease. 114
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 113
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 113
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 113
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 112
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 112
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 112
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 111
Gait patterns and cognition in Parkinson's disease 109
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 108
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 107
Cognitive contributions to gait and falls: Evidence and implications 104
The "eye of the tiger" sign in pure akinesia with gait freezing. 103
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 103
Parkinson’s disease and the spectrum of Lewy body disease 103
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 101
Development of software tool for quantitative gait assessment in Parkinsonian patients with and without Mild Cognitive Impairment 101
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 100
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 100
Resting brain networks in patients with Parkinson's disease and freezing of gait 100
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 99
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 99
Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson's disease 98
Performing a short sway to distinguish Parkinsonisms 97
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 97
Totale 20.507
Categoria #
all - tutte 76.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202616.449 1.587 4.538 3.992 682 920 437 1.312 305 431 884 248 1.113
2026/2027496 496 0 0 0 0 0 0 0 0 0 0 0
Totale 26.606